FMO5 and Hyperglycemia: Oxidative stress caused by different sources can dampen NO availability [68], i.e., Aβ-peptide, angiotensin II, and hyperglycemia can stimulate NADPH oxidase and decrease NO levels in endothelial cells in vitro.